Sandeep Yadav, Ph.D.

Bio:

Sandeep Yadav, Ph.D., is currently Vice President, Technical Development at Sangamo Therapeutics, advancing genomic medicines from discovery to commercialization. Prior to Sangamo, he held several leadership position at Genentech/Roche and contributed to various clinical and commercial programs including; Tacentriq®, Ocrevus®, Rituxan®, Avastin®, and Pulmozyme®. He has led CMC strategy from clinical development and commercialization across biologics, cell and gene therapies, and small molecules. Dr. Yadav brings deep expertise in process development, manufacturing, and global regulatory submissions. A recognized thought leader with ~30 publications and patents, he actively engages in industry forums and is passionate about building high-performing teams through mentorship, strategic leadership, and collaborative execution.